European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078)
Open Access
- 1 July 1995
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 101 (Supplement) , 29-34
- https://doi.org/10.1111/j.1365-2249.1995.tb06161.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CLASSIFICATION AND EPIDEMIOLOGY OF SYSTEMIC VASCULITISRheumatology, 1994
- Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with wegener's granulomatosisArthritis & Rheumatism, 1994
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Long-term remission of intractable systemic vasculitis with monoclonal antibody therapyThe Lancet, 1993
- Cellular Immune Responses and Pathogenesis in c-ANCA Positive VasculitidesJournal of Autoimmunity, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodiesKidney International, 1991
- Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titreThe Lancet, 1990
- Methylprednisolone Therapy for Acute Crescentic Rapidly Progressive GlomerulonephritisAmerican Journal of Nephrology, 1989
- The treatment of wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision?Arthritis & Rheumatism, 1988